Chances are the only “Bubble Boy” you’re familiar with was arguing that the Moors invaded Spain in 8th Century. Or was it the Moops? Regardless, a recent Bloomberg article contained good news for bubble boys everywhere: a cure has been found! Bubble Boy Disease refers to an immune-system deficiency so severe that children were at one time kept in total isolation for fear that any attack on the immune system could be lethal.
A team of researchers at St. Jude Children’s Research Hospital in Memphis has developed a personalized gene therapy treatment to correct the genetic issue. It proved successful in eight male infants who are now toddlers who are leading normal lives. St. Jude licensed the therapy to Mustang Bio Inc., a small biopharmaceutical company that plans to file for global regulatory approval by the end of 2021.
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
